HOME >> BIOLOGY >> NEWS
BioMed Central explodes Open Access myths

"A switch to Open Access would not negatively impact research funding," BioMed Central declared today. The Open Access publisher issued a strong rebuttal of arguments that have been submitted by opponents of Open Access to the ongoing UK House of Commons Select Committee inquiry into scientific publishing.

In (Mis)Leading Open Access Myths <http://www.biomedcentral.com/openaccess/inquiry/myths.pdf>, a statement released today, BioMed Central counters claims that Open Access publishing would cut into research funding, asserting:

"The vastly increased access to research that is delivered by Open Access will greatly increase the effectiveness of the research money that is spent."

The statement continues:

"Open Access publishers are leading the way in using web technology to reduce costs further, so the cost of. Open Access publishing to the scientific community will be significantly less than the cost of the system that it replaces."

Open Access publishing, which makes all original research articles freely available to anyone, has been a major focus of the Government inquiry.

Today's statement from BioMed Central responds to each of the major "anti-Open Access" arguments made during the course of the inquiry so far.

"We felt it was important, at this stage when many people are hearing about Open Access for the first time, to dispel some of these myths," says Jan Velterop, BioMed Central's Publisher.

Other myths dispelled in the document include: "transferring copyright to a publisher protects scientific integrity"; "UK researchers already have all the access they need"; "industry will benefit from Open Access at the expense of research institutes"; and "the public would be confused if they had access to medical research".

The BioMed Central statement appears on a new web page <

Contact: Grace Baynes
press@biomedcentral.com
44-20-7631-9988
BioMed Central
22-Mar-2004


Page: 1 2

Related biology news :

1. BioMed Central to consult funders and librarians over Open Access payment model
2. LA BioMed Medical/Research Briefs, July/August 2004
3. The Scientist and BioMed Central come together to publish high-impact magazine
4. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
5. BioMed Central to deposit e-journals with the British Library
6. BioMed Central to consider charging authors for paper submissions
7. Get Research on the move with BioMed Central
8. BioMed Central to launch at microbiology meeting
9. BioMed Central to free scientists and clinical researchers from copyright restrictions
10. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
11. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 08, 2020 , ... ... Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 ... but what is the most effective way to complete one? Will the study ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), ... Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
(Date:7/31/2020)... ... July 29, 2020 , ... The SDX® Respiratory ... 16 countries, has reached its 20th anniversary of worldwide use. Introduced in the ... top universities including University of Pennsylvania, University of Michigan, University of Maryland, University ...
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 16, 2020 , ... After ... begins. The completion of a great surgery is only the beginning of a successful ... the research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
Breaking Biology Technology:
Cached News: